Srinivas Rao
Sanofi (United States)(US)
Publications by Year
Research Areas
Systemic Lupus Erythematosus Research, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Rheumatoid Arthritis Research and Therapies, Systemic Sclerosis and Related Diseases
Most-Cited Works
- → Prospects for a safe COVID-19 vaccine(2020)274 cited
- → Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation(2019)243 cited
- → CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates(2011)224 cited
- → The timing of death in patients with tuberculosis who die during anti-tuberculosis treatment in Andhra Pradesh, South India(2011)50 cited
- → ACTIVating Resources for the COVID-19 Pandemic: In Vivo Models for Vaccines and Therapeutics(2020)46 cited
- → An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis(2022)37 cited
- → CRISPR/Cas9 generated knockout mice lacking phenylalanine hydroxylase protein as a novel preclinical model for human phenylketonuria(2021)15 cited
- → Translational strategy using multiple nuclear imaging biomarkers to evaluate target engagement and early therapeutic efficacy of SAR439859, a novel selective estrogen receptor degrader(2020)14 cited
- → AB1372 Towards reforming the taxonomy of human disease: the precisesads cross sectional study(2018)1 cited
- → Corrigendum: An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis(2024)1 cited